Both in Pharmaceuticals
Rapport Therapeutics vs Kardigan
Over the past year RAPP returned −42.6% and KARD returned −23.7%; their daily moves had a correlation of 0.53.
RAPP −42.6% KARD −23.7%Growth of $1, one year, split-adjusted
| Metric | RAPP | KARD |
|---|---|---|
| Price | $25.05 | $14.13 |
| Market cap | $1.41B | $1.32B |
| Today | +3.47% | −1.26% |
| 1 month | −23.7% | −0.8% |
| 6 months | −26.1% | — |
| Year to date | −17.4% | — |
| 1 year | −8.5% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 70.5× | — |
| Net cash | $436.1M | $597.6M |
| Dividend yield | — | — |
| Volatility (60d) | 79.8% | — |
| Short % of float | 10.9% | 13.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).